Patents by Inventor Bernd Buchberger

Bernd Buchberger has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11098298
    Abstract: The present invention provides a novel method for the recombinant production of Factor C protein from horseshoe crab using a parasitic protozoan expressing the Factor C protein. In particular, the present invention provides a parasitic protozoan host cell harbouring a polynucleotide encoding horseshoe crab Factor C protein, and a method for producing Factor C protein comprising culturing said parasitic protozoan host cell under conditions such that the cells express the horseshoe crab Factor C protein. Furthermore, the present invention provides recombinant Factor C protein produced by the novel method and its use in the detection and/or removal of endotoxin.
    Type: Grant
    Filed: May 1, 2019
    Date of Patent: August 24, 2021
    Assignee: BIOMÉRIEUX DEUTSCHLAND GMBH
    Inventors: Bernd Buchberger, Holger Grallert, Sonja Molinaro
  • Patent number: 11092592
    Abstract: The invention relates to unmasking endotoxins in compositions so that previously present, but undetectable endotoxins are rendered detectable.
    Type: Grant
    Filed: January 30, 2020
    Date of Patent: August 17, 2021
    Assignee: BIOMÉRIEUX DEUTSCHLAND GMBH
    Inventor: Bernd Buchberger
  • Publication number: 20200166500
    Abstract: The invention relates to unmasking endotoxins in compositions so that previously present, but undetectable endotoxins are rendered detectable.
    Type: Application
    Filed: January 30, 2020
    Publication date: May 28, 2020
    Applicant: HYGLOS INVEST GMBH
    Inventor: Bernd BUCHBERGER
  • Patent number: 10655113
    Abstract: The present invention relates to novel methods of generating and screening for chimeric polypeptides, which can be used in the treatment and prophylaxis of pathogenic bacterial contamination, colonisation and infection. The novel methods are based on random recombination of protein domains, and the chimeric polypeptides obtainable by the methods according to the invention are characterized in that they comprise at least one enzymatic active domain (EAD) and at least one cell binding domain (CBD). The present invention also relates to a library of chimeric polypeptides obtainable by the methods of the present invention.
    Type: Grant
    Filed: April 22, 2019
    Date of Patent: May 19, 2020
    Assignee: HYPHARM GMBH
    Inventors: Anna Scherzinger, Sonja Molinaro, Bernd Buchberger
  • Patent number: 10585086
    Abstract: The invention relates to unmasking endotoxins in compositions so that previously present, but undetectable endotoxins are rendered detectable.
    Type: Grant
    Filed: June 12, 2015
    Date of Patent: March 10, 2020
    Assignee: HYGLOS INVEST GMBH
    Inventor: Bernd Buchberger
  • Publication number: 20190256836
    Abstract: The present invention provides a novel method for the recombinant production of Factor C protein from horseshoe crab using a parasitic protozoan expressing the Factor C protein. In particular, the present invention provides a parasitic protozoan host cell harbouring a polynucleotide encoding horseshoe crab Factor C protein, and a method for producing Factor C protein comprising culturing said parasitic protozoan host cell under conditions such that the cells express the horseshoe crab Factor C protein. Furthermore, the present invention provides recombinant Factor C protein produced by the novel method and its use in the detection and/or removal of endotoxin.
    Type: Application
    Filed: May 1, 2019
    Publication date: August 22, 2019
    Applicant: HYGLOS INVEST GMBH
    Inventors: Bernd BUCHBERGER, Holger GRALLERT, Sonja MOLINARO
  • Publication number: 20190249156
    Abstract: The present invention relates to novel methods of generating and screening for chimeric polypeptides, which can be used in the treatment and prophylaxis of pathogenic bacterial contamination, colonisation and infection. The novel methods are based on random recombination of protein domains, and the chimeric polypeptides obtainable by the methods according to the invention are characterized in that they comprise at least one enzymatic active domain (EAD) and at least one cell binding domain (CBD). The present invention also relates to a library of chimeric polypeptides obtainable by the methods of the present invention.
    Type: Application
    Filed: April 22, 2019
    Publication date: August 15, 2019
    Applicant: HYPHARM GMBH
    Inventors: Anna SCHERZINGER, Sonja MOLINARO, Bernd BUCHBERGER
  • Patent number: 10323238
    Abstract: The present invention provides a novel method for the recombinant production of Factor C protein from horseshoe crab using a parasitic protozoan expressing the Factor C protein. In particular, the present invention provides a parasitic protozoan host cell harbouring a polynucleotide encoding horseshoe crab Factor C protein, and a method for producing Factor C protein comprising culturing said parasitic protozoan host cell under conditions such that the cells express the horseshoe crab Factor C protein. Furthermore, the present invention provides recombinant Factor C protein produced by the novel method and its use in the detection and/or removal of endotoxin.
    Type: Grant
    Filed: June 28, 2017
    Date of Patent: June 18, 2019
    Assignee: HYGLOS INVEST GMBH
    Inventors: Bernd Buchberger, Holger Grallert, Sonja Molinaro
  • Patent number: 10301607
    Abstract: The present invention relates to novel methods of generating and screening for chimeric polypeptides, which can be used in the treatment and prophylaxis of pathogenic bacterial contamination, colonization and infection. The novel methods are based on random recombination of protein domains, and the chimeric polypeptides obtainable by the methods according to the invention are characterized in that they comprise at least one enzymatic active domain (EAD) and at least one cell binding domain (CBD). The present invention also relates to a library of chimeric polypeptides obtainable by the methods of the present invention.
    Type: Grant
    Filed: January 20, 2016
    Date of Patent: May 28, 2019
    Assignee: HYPHARM GMBH
    Inventors: Anna Scherzinger, Sonja Molinaro, Bernd Buchberger
  • Publication number: 20170306315
    Abstract: The present invention provides a novel method for the recombinant production of Factor C protein from horseshoe crab using a parasitic protozoan expressing the Factor C protein. In particular, the present invention provides a parasitic protozoan host cell harbouring a polynucleotide encoding horseshoe crab Factor C protein, and a method for producing Factor C protein comprising culturing said parasitic protozoan host cell under conditions such that the cells express the horseshoe crab Factor C protein. Furthermore, the present invention provides recombinant Factor C protein produced by the novel method and its use in the detection and/or removal of endotoxin.
    Type: Application
    Filed: June 28, 2017
    Publication date: October 26, 2017
    Applicant: HYGLOS INVEST GMBH
    Inventors: Bernd BUCHBERGER, Holger GRALLERT, Sonja MOLINARO
  • Publication number: 20170227529
    Abstract: The invention relates to unmasking endotoxins in compositions so that previously present, but undetectable endotoxins are rendered detectable.
    Type: Application
    Filed: June 12, 2015
    Publication date: August 10, 2017
    Applicant: HYGLOS INVEST GMBH
    Inventor: Bernd BUCHBERGER
  • Patent number: 9725706
    Abstract: The present invention provides a novel method for the recombinant production of Factor C protein from horseshoe crab using a parasitic protozoan expressing the Factor C protein. In particular, the present invention provides a parasitic protozoan host cell harboring a polynucleotide encoding horseshoe crab Factor C protein, and a method for producing Factor C protein comprising culturing said parasitic protozoan host cell under conditions such that the cells express the horseshoe crab Factor C protein. Furthermore, the present invention provides recombinant Factor C protein produced by the novel method and its use in the detection and/or removal of endotoxin.
    Type: Grant
    Filed: December 4, 2013
    Date of Patent: August 8, 2017
    Assignee: HYGLOS INVEST GMBH
    Inventors: Bernd Buchberger, Holger Grallert, Sonja Molinaro
  • Patent number: 9453842
    Abstract: The present invention deals with reagents and compositions capable of effectively inhibiting peroxidase activity. According to the invention, peroxidase enzymatic activity is blocked with an acidic aqueous solution of a protein denaturing agent. Preferred protein denaturing agents are detergents and chaotropic substances.
    Type: Grant
    Filed: April 9, 2014
    Date of Patent: September 27, 2016
    Assignee: Roche Molecular Systems, Inc.
    Inventors: Manfred Watzele, Bernd Buchberger, Claudia Kirr
  • Publication number: 20160137993
    Abstract: The present invention relates to novel methods of generating and screening for chimeric polypeptides, which can be used in the treatment and prophylaxis of pathogenic bacterial contamination, colonisation and infection. The novel methods are based on random recombination of protein domains, and the chimeric polypeptides obtainable by the methods according to the invention are characterized in that they comprise at least one enzymatic active domain (EAD) and at least one cell binding domain (CBD). The present invention also relates to a library of chimeric polypeptides obtainable by the methods of the present invention.
    Type: Application
    Filed: January 20, 2016
    Publication date: May 19, 2016
    Applicant: HYGLOS INVEST GMBH
    Inventors: Anna Scherzinger, Sonja Molinaro, Bernd Buchberger
  • Patent number: 9249447
    Abstract: The present invention relates to novel methods of generating and screening for chimeric polypeptides, which can be used in the treatment and prophylaxis of pathogenic bacterial contamination, colonization and infection. The novel methods are based on random recombination of protein domains, and the chimeric polypeptides obtainable by the methods according to the invention are characterized in that they comprise at least one enzymatic active domain (EAD) and at least one cell binding domain (CBD). The present invention also relates to a library of chimeric polypeptides obtainable by the methods of the present invention.
    Type: Grant
    Filed: June 17, 2011
    Date of Patent: February 2, 2016
    Assignee: HYGLOS INVEST GMBH
    Inventors: Anna Scherzinger, Sonja Molinaro, Bernd Buchberger
  • Publication number: 20150299684
    Abstract: The present invention provides a novel method for the recombinant production of Factor C protein from horseshoe crab using a parasitic protozoan expressing the Factor C protein. In particular, the present invention provides a parasitic protozoan host cell harbouring a polynucleotide encoding horseshoe crab Factor C protein, and a method for producing Factor C protein comprising culturing said parasitic protozoan host cell under conditions such that the cells express the horseshoe crab Factor C protein. Furthermore, the present invention provides recombinant Factor C protein produced by the novel method and its use in the detection and/or removal of endotoxin.
    Type: Application
    Filed: December 4, 2013
    Publication date: October 22, 2015
    Applicant: MICROCOAT BIOTECHNOLOGIE GMBH
    Inventors: Bernd BUCHBERGER, Holger GRALLERT, Sonja MOLINARO
  • Patent number: 8951780
    Abstract: The invention concerns a method for isolating and purifying nucleic acids from large sample volumes and a device suitable for this. The device comprises a funnel, a separating column, and a tab which are detachable from each other. The method according to the invention in which the device according to the invention is used ensures a higher yield of nucleic acids.
    Type: Grant
    Filed: October 30, 2008
    Date of Patent: February 10, 2015
    Assignee: Roche Molecular Systems, Inc.
    Inventors: Maximilian Ruhstorfer, Bernd Buchberger, Horst Donner, Alois Rainer
  • Publication number: 20140220593
    Abstract: The present invention deals with reagents and compositions capable of effectively inhibiting peroxidase activity. According to the invention, peroxidase enzymatic activity is blocked with an acidic aqueous solution of a protein denaturing agent. Preferred protein denaturing agents are detergents and chaotropic substances.
    Type: Application
    Filed: April 9, 2014
    Publication date: August 7, 2014
    Inventors: Manfred WATZELE, Bernd BUCHBERGER, Claudia KIRR
  • Patent number: 8735083
    Abstract: The present invention deals with reagents and compositions capable of effectively inhibiting peroxidase activity. According to the invention, peroxidase enzymatic activity is blocked with an acidic aqueous solution of a protein denaturing agent. preferred protein denaturing agents are detergents and chaotropic substances.
    Type: Grant
    Filed: June 6, 2007
    Date of Patent: May 27, 2014
    Assignee: Roche Diagnostics Operations, Inc.
    Inventors: Manfred Watzele, Bernd Buchberger, Claudia Kirr
  • Publication number: 20130288926
    Abstract: The present invention relates to novel methods of generating and screening for chimeric polypeptides, which can be used in the treatment and prophylaxis of pathogenic bacterial contamination, colonisation and infection. The novel methods are based on random recombination of protein domains, and the chimeric polypeptides obtainable by the methods according to the invention are characterized in that they comprise at least one enzymatic active domain (EAD) and at least one cell binding domain (CBD). The present invention also relates to a library of chimeric polypeptides obtainable by the methods of the present invention.
    Type: Application
    Filed: June 17, 2011
    Publication date: October 31, 2013
    Applicant: HYGLOS INVEST GMBH
    Inventors: Anna Scherzinger, Sonja Molinaro, Bernd Buchberger